IMPACT ON OVERALL SURVIVAL RATE IN PANCREATIC CANCER WITH AYURVEDIC RASAYANA THERAPY - A CASE SERIES OF 4 PATIENTS
DOI:
https://doi.org/10.70066/jahm.v4i1.293Keywords:
Pancreatic cancer, Rasayana therapy, AyurvedaAbstract
Pancreatic cancer is known for one of the worst prognosis in different kinds of cancer. In spite of advances in
chemotherapy and Immunotherapy medical science has failed to achieve satisfactory success in improving
survival in patients of pancreatic cancer. In advanced stage pancreatic cancer patients the expected median
survival rate is to be only three to six months. Moreover the quality of life in such patients is highly
compromised. Ayurvedic Rasayana therapy has shown promising results in improving overall therapeutic
outcomes in patients of pancreatic cancer. Ayurveda therapy has not only shown to improve quality of life in
such patients but it has also significantly increased patients survival and need for requirement of conventional
palliative care therapies. The present article puts a light on Ayurvedic aspects about management of Patients
with pancreatic cancer and also discusses few case studies of pancreatic cancer patients treated successfully by
Author and his team using Rasayana therapy.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 YOGESH NARAYAN BENDALE

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.